KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
GMR Compounds: 26 Kovera certificates.
The lab's record shows 26 certificates printed for GMR Compounds, analysed between 26 Apr 2026 and 20 May 2026, covering 19 products. Median HPLC purity is 99.77%. Kovera graded 26 as a pass and 0 as a fail.
26
certificates
99.77%
median purity
19
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 26 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 9 measured more than 110% of the label, which Kovera does not grade as a fail.
Kovera revised 1 of these certificates after first publication, under the same report number: KVR-2026-D64DF4 (revised by the lab 2026-06-06, figures unchanged). Why that matters is in our revisions analysis.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
19 AS PRINTEDRetatrutide · 3BPC-157/TB-500 · 2CJC-1295 (No DAC)/Ipamorelin · 2GHK-Cu · 2MOTS-c · 2Tesamorelin · 2BPC-157 · 1CJC-1295 no DAC · 1Epithalon · 1Glow · 1Glutathione · 1IGF-1 LR3 · 1Ipamorelin · 1Klow · 1Melanotan-2 · 1NAD+ · 1Selank · 1Semax · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 26 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-F00911 | MOTS-c | GMR-2026-MOT-01B | 99.899% | 105.1%42.04 of 40 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D64DF4 | Glutathione | GMR-2026-GLU-01A | 99.131% | 96.7%1449.83 of 1500 mg | 20 May 2026 | PASSrevised by the lab 2026-06-06, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-CE2E62 | Selank | GMR-2026-SLNK-01A | 99.636% | 113.2%5.66 of 5 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C50AD9 | NAD+ | GMR-2026-NAD-02B | 99.649% | 105.2%1051.95 of 1000 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AEBCF8 | CJC-1295 (No DAC)/Ipamorelin | GMR-2026-CJCIPA-01A | 99.867% | 101.2%10.12 of 10 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AA06F7 | CJC-1295 (No DAC)/Ipamorelin | GMR-2026-CJCIPA-02A | 99.699% | 111.8%11.18 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A75D4B | BPC-157 | GMR-2026-BPC-01A | 99.977% | 105.7%10.57 of 10 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9ABE16 | Epithalon | GMR-2026-EPI-01A | 99.422% | 106.6%53.28 of 50 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9242B9 | Tirzepatide | GMR-2026-TRZ-01A | 98.717% | 104.8%20.97 of 20 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8BE215 | Retatrutide | GMR-2026-RTA-01C | 99.709% | 109.6%21.92 of 20 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-723A95 | Semax | GMR-2026-SMX-01A | 99.957% | 118.8%5.94 of 5 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6984A4 | Melanotan-2 | GMR-2026-MT2-01A | 99.487% | 99.1%9.91 of 10 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-51AEC2 | BPC-157/TB-500 | GMR-2026-BPCTB-02A | 99.756% | 113.0%22.6 of 20 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-48D44A | GHK-Cu | GMR-2026-GHK-02B | 99.397% | 108.9%108.91 of 100 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3A42B5 | Tesamorelin | GMR-2026-TES-02B | 99.263% | 111.6%11.16 of 10 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3232FB | Klow | GMR-2026-KLOW-01A | 99.784% | 107.2%85.72 of 80 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1AB871 | Retatrutide | GMR-2026-RTA-01B | 99.408% | 107.7%32.31 of 30 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-147416 | Glow | GMR-2026-GLOW-01A | 99.864% | 108.2%75.75 of 70 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-013B79 | Retatrutide | GMR-2026-RTA-01A | 99.973% | 112.1%16.81 of 15 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-F2DC30 | Ipamorelin | GMR-2026-IPA-01A | 99.858% | 93.1%9.31 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D90543 | BPC-157/TB-500 | GMR-2026-BPCTB-01A | 99.456% | 99.8%19.96 of 20 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B9AAD4 | Tesamorelin | GMR-2026-TES-01A | 99.887% | 123.8%12.38 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4DA2D0 | IGF-1 LR3 | GMR2026-IGF-01A | 99.983% | 111.0%1.11 of 1 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-467DFA | MOTS-c | GMR-2026-MOT-01A | 99.858% | 107.3%10.73 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-28F982 | GHK-Cu | GMR-2026-GHK-01B | 99.883% | 106.8%106.78 of 100 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-06DDB4 | CJC-1295 no DAC | GMR-2026CJCND-01A | 99.839% | 117.6%11.76 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |